Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,349 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 301-325 of 916 matching filings.

Per page
25
Current page
13
4

4 filing

Filing date
29 May 2019
Reporting date
29 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
29 May 2019
Reporting date
29 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-56243

SC 13D

Filing date
09 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
09 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56243

SC 13G/A

Filing date
29 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-31326

DEFA14A

Filing date
05 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-31326

DEF 14A

Filing date
05 Apr 2019
Reporting date
29 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Mar 2019
Reporting date
26 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
08 Mar 2019
Reporting date
08 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56243

SC 13G/A

Filing date
11 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56243

SC 13G/A

Filing date
06 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
01 Feb 2019
Reporting date
30 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2019
Reporting date
30 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2019
Reporting date
30 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2019
Reporting date
30 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2019
Reporting date
30 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2019
Reporting date
30 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Dec 2018
Reporting date
26 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-228430

EFFECT filing

Filing date
26 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-228430

FORM S-3

Filing date
16 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
16 Nov 2018
Reporting date
16 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .